Hexarelin (Examorelin) 2mg

Hexarelin (Examorelin) is a synthetic hexapeptide growth hormone secretagogue and one of the most potent GHS-R1a agonists identified. Binding to GHS-R1a activates Gq/11-mediated phospholipase C signalling, resulting in IP3/DAG generation, intracellular calcium mobilization, and downstream secretagogue-associated signalling pathways. Unlike other members of the GHRP class, Hexarelin also interacts with CD36 (scavenger receptor class B), providing a secondary signalling mechanism independent of GHS-R1a activation. This dual receptor profile makes Hexarelin a valuable research tool for investigating GHS-R1a pharmacology, receptor-signalling dynamics, secretagogue potency relationships, CD36-mediated signalling pathways, and comparative peptide pharmacology. Experimental studies have also utilized Hexarelin in investigations of receptor cross-talk, intracellular signalling networks, and peptide-receptor selectivity. Supplied as lyophilized preparation (2 mg/vial).